📢Check out the new edition of the #Inforecerca newsletter from the @researchmar.bsky.social 's Research Service. 📰Stay updated on the latest research and publication opportunities! 👉Visit now: https://intranet.imim.cat/inforecerca?id=1162  @hospitaldelmar.bsky.social  @prbb.org

📢Vols contribuir a atraure i desenvolupar el talent en la recerca biomèdica? 🌊Busquem Tècnic/a de Persones i Cultura per impulsar la captació, el desenvolupament i la fidelització del talent a l' @researchmar.bsky.social. 🗓️Fins el 22/07. ✍️ https://www.researchmar.net/ofertes/detall-oferta.html?id=78

🧠Dr Manuel Valero, coordinator of the Neural Computation Lab at the @researchmar.bsky.social #HMRIB, has been selected to join the FENS-Kavli Scholars network run by @fens.org. 🏅A recognition of his scientific leadership. 👉Find out more: www.researchmar.net/news/866 #Neuroscience #Research

🏅Further recognition of talent #HMRIB 🧠Dr Sara Mederos & Dr Manuel Valero, coords. at @researchmar.bsky.social Neural Lab, appointed as Young Ambassadors for @senc-neurociencia.bsky.social at @fens.org Fòrum26 ✨Scientific excellence, leadership & commitment 👏Congrats! 📰 www.researchmar.net/news/867

🧸Did you know that childhood trauma can also affect physical health? 🌊A study by @researchmar.bsky.social #HMRIB found that childhood trauma increases the risk of developing physical illnesses in adulthood by 1.57 times. 🔬Published in @eclinicalmed.bsky.social  📖 https://www.researchmar.net/news/842

👅Can a saliva sample predict when the brain is ready to learn? 🧠A study led by @incuab.bsky.social in collaboration with @researchmar.bsky.social #HMRIB shows that the progesterone-to-oestradiol ratio could predict memory performance. 🗞️More: www.researchmar.net/news/849/ #research #neuroscience

🥗What is the link between dietary habits and brain health? 🧠High levels of palmitoleic acid have been linked to an impaired ability to metabolise glucose in the brain, according to @researchmar.bsky.social #HMRIB & #CNIC_CARDIO. ➕About the study: www.researchmar.net/news/859

🧬 #DarkProteome: little-known proteins could open up new avenues of research 🌊The @researchmar.bsky.social #HMRIB is the only institution in Spain taking part in the #OrFeus, to study the ‘dark proteome’. 👉 www.researchmar.net/news/865 @maralbalab.bsky.social @icreacommunity.bsky.social #Proteomics

🎥The award-winning research explained by Aura Muntasell. 🏆The researcher from the @researchmar.bsky.social #HMRIB has won the @lavanguardia.com Science Prize #FCLaPedrera for a study published in @nature.com on the genetic editing of NK cells. 👉More: www.researchmar.net/news/864 #Cancer #Research

🎥La recerca premiada explicada per l'Aura Muntasell 🏆La investigadora de @researchmar.bsky.social #HMRIB guanya el Premi @lavanguardia.com de la Ciència #FCLaPedrera pel seu estudi publicat a @nature.com sobre edició genètica de cèl·lules NK 👉Més www.researchmar.net/noticies/1499 #Oncologia #Recerca

🧬Innovation = turning ideas into impact 🌊The @researchmar.bsky.social #HMRIB has achieved ISO 56001:2024 certification, reinforcing model of responsible innovation aimed at generating value through biomedical research 🏅It consolidates a path that began with UNE 166002 🗞️ www.researchmar.net/news/863

📢Check out the new edition of the #Inforecerca newsletter from the @researchmar.bsky.social 's Research Service. 📰Stay updated on the latest research and publication opportunities! 👉Visit now: intranet.imim.cat/inforecerca?... @hospitaldelmar.bsky.social @prbb.org

🫀How can data help in the event of a heart attack? 🌊The IAM-CAT, by @researchmar.bsky.social #HMRIB & @hospitaldelmar.bsky.social has been awarded the Bronze Prize at the SNS's Best Practice Event. 📊Integrated registry of acute myocardial infarction cases in Catalonia. 📰 www.researchmar.net/news/860

🚀How does research translate into impact? 🌊The @researchmar.bsky.social #HMRIB has set up the Impact Dept led by Ismael Ávila. This cross-functional structure is designed to generate, measure, transfer & communicate the value of research & innovation. 🗞️More: www.researchmar.net/news/858/ #Innovation

🧠What could explain a complication affecting 1 in 4 people following a subarachnoid haemorrhage? 🌊A study led by @researchmar.bsky.social #HMRIB links variants in COL6A6 & PIK3R4 to an increased risk of delayed cerebral ischaemia. 🔍Read more: www.researchmar.net/news/857

🧠Què pot explicar una complicació que afecta 1 de 4 persones després d'una hemorràgia subaracnoidal? 🌊Un estudi liderat per @researchmar.bsky.social #HMRIB associa variants de COL6A6 i PIK3R4 amb increment de risc d'isquèmia cerebral retardada. 🔍Llegeix més: www.researchmar.net/noticies/1492

🧬How can we make tumour cells +visible? 🏅Dr @tceliaterrassa.bsky.social, @researchmar.bsky.social #HMRIB, granted €2.5m by @erc.europa.eu to lead the #PLASTWIRE project: 5years to explore mRNA therapies that reprogramme tumour plasticity in breast cancer 📰Read+: www.researchmar.net/noticias/1338

🧬Com fer +visibles les cèl·lules tumorals? 🏅Dr @tceliaterrassa.bsky.social, @researchmar.bsky.social #HMRIB, rep 2,5M€ de @erc.europa.eu per liderar el projecte #PLASTWIRE: 5anys per explorar teràpies mRNA que reprogramin la plasticitat tumoral en càncer de mama 📰 www.researchmar.net/noticies/1491/

🧠How do the body, brain & consciousness interact under the influence of #ayahuasca? 🌊A study by @researchmar.bsky.social #HMRIB, in collab with @maastrichtu.bsky.social & @goetheuni.bsky.social, investigates how its effects are linked to metabolic & cerebral changes. 📚 www.researchmar.net/news/855/

🛡️A possible key to activating immunity in ‘cold’ tumours. 🧪A study in mice, led by the @researchmar.bsky.social #HMRIB & the #IIBB-CSIC, identified PARP2 as a potential therapeutic target against pancreatic cancer. 🔗Read more: www.researchmar.net/news/840

🍄 #SalutiCiència - Psicodèlics: experiència espiritual o futur tractament? 🧪Demà, Francisco Madrid parlarà sobre l'evidència científica dels psicodèlics. 🗓️18/6|⌚18:30h 📍Biblioteca Barceloneta - La Fraternitat 👉 www.researchmar.net/agenda/1053 @bibliotequesbcn.bsky.social @researchmar.bsky.social

🔬How can AI be used to prevent suicide or respond to a stroke? 🧠At 'Visita la recerca de La Marató', citizens discovered some innovative mental health and stroke projects, and how research can improve clinical decision-making, at @researchmar.bsky.social 👉Read more: www.researchmar.net/news/854

🌊The @hospitaldelmar.bsky.social has been designated an “EU-Designated CCC” by #EUnetCCC. 🇪🇺This recognition reinforces the link between clinical excellence, biomedical research and innovation to advance cancer prevention, diagnosis and treatment. 🔗 www.researchmar.net/news/853

🚀The 1st edition of the MAR TECH TRANSFER Academy has come to a close. +50 professionals took part, & six projects with the potential to transform healthcare were graduated 🔬The programme was driven by Transfer & Translation Unit at the @researchmar.bsky.social #HMRIB. 👉 www.researchmar.net/news/852

🚀La 1a edició de MAR TECH TRANSFER Academy ha finalitzat amb +50 professionals participants i la graduació de 6 projectes amb potencial per transformar la salut. 🔬Un programa impulsat per la Unitat de Transferència i Translació del @researchmar.bsky.social #HMRIB 👉 www.researchmar.net/noticies/1487

🧬A new project led by Anna Bigas @researchmar.bsky.social #HMRIB @carrerasijc.bsky.social to understand resistance to chemotherapy in T-ALL & open up new therapeutic paths. 👥With Prof. Christoph Plass @dkfz.bsky.social the team will use single-cell tech. 🗞️ www.researchmar.net/news/851 #JCLStiftung

🧬Nou projecte liderat per Anna Bigas @researchmar.bsky.social #HMRIB @carrerasijc.bsky.social per entendre la resistència a la quimio en T-ALL i obrir noves vies terapèutiques 👥Amb Prof. Christoph Plass @dkfz.bsky.social usant tecnologies single-cell 🗞️ www.researchmar.net/noticies/1486 #JCLStiftung

🚀From idea to patient: Last call to join the #HMRIB MAR TECH TRANSFER Academy. 🗓️Today 10/06 | 🕓4pm 🗣️Jordi Martorell #Aortyx 📍Charles Darwin Room @prbb.org ✍️ www.researchmar.net/agenda/1046/ 📸We also share pics from previous session with Mercè de Frias & Valerie Vanhooren from #OnaTherapeutics

🧠New clinical trial could open up new treatments for FragileX syndrome ⚗️ #CONNECTATherapeutics is launching a Phase IIa trial with CTH120. Dr Rafael de la Torre @researchmar.bsky.social HMRIB Dr Ana Aldea #HMRIB Dr Ana Roche #I3PT & Dr @maradierssen.bsky.social @crg.eu 👉 www.researchmar.net/news/850

🧪+100 professionals gathered to tackle the challenges of clinical trials in #HorizonEurope 🌊The @researchmar.bsky.social #HMRIB event brought together research management staff from +40 institutes to share experiences on: budgets, consortium coordination & regulations. 🔗 www.researchmar.net/news/847